Abstract:

Drug and Therapeutics Committees (DTCs) have been identified and promoted as a fundamental model in advancing the rational management and use of essential medicines and health supplies in hospitals since the 1970s. However, there is still a scarcity of comprehensive literature on their current structure and actual roles performed in various countries. We conducted a scoping review using the Pubmed and ResearchGate databases and included eligible articles published between 2010 and 2023, to assess the structure and roles performed by hospital DTCs. The database search yielded 47 potential records, but only seven of these were eligible for inclusion. Studies included were from both high-income and low- and middle-income countries. The structure of DTCs is generally similar across these countries, with minor contextual variations. All DTCs are heterogeneous in composition and contain both medical and non-medical staff. The DTC leadership comprises a chairperson who is usually a senior clinician, and a secretary who is usually a pharmacist. The majority of the DTCs have at least one sub-committee, and antimicrobial stewardship is the most common. The DTCs still perform their customary roles, although their role scope is expanding. In some countries, the DTCs have taken on additional roles due to the evolving medicines management and use problems, and technologies. There is however still a dearth of recent primary data on the structure and roles of DTCs in many countries. We recommend more primary research to understand the status of DTCs in various countries and to provide more insights into the existence and functionality of the DTC sub-committees.

References:

[1] Religioni U, Pakulska T. Rational drug use in hospital settings – areas that can be changed. J Med Econ [Internet]. 2020;23(10):1205–8. Available from: https://doi.org/10.1080/13696998.2020.1801455.

[2] Tan EL, Pharm B, Hons BP, Ph D, Day RO, P FRAC, et al. Perspectives on Drug and Therapeutics Committee policy implementation. 2010;1(2005):526–45.

[3] World Health Organization. Drug and Therapeutics Committees. A practical Guide. Holloway K, Terry G, editors. Geneva: World Health Organization; 2003.

[4] Tan EL, Day RO, Brien J anne E. Drug and therapeutics committees — are they fulfilling their potential to improve the quality use of medicines? Int J Pharm Pract. 2010;11(3):175–81.

[5] Fadare JO, Ogunleye O, Obiako R, Orubu S, Enwere O, Ajemigbitse AA, et al. Expert Review of Clinical Pharmacology Drug and therapeutics committees in Nigeria: evaluation of scope and functionality. Expert Rev Clin Pharmacol [Internet]. 2018;11(12):1255–62. Available from: https://doi.org/10.1080/17512433.2018.1549488.

[6] Res M. Rational use of medicines: Cost consideration & way forward. 2016;(October):502–5.

[7] Shankar PR, Humagain ÆB, Nisha RMPÆ, Bidur JÆ. Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences. 2009;241–5.

[8] Seyoum H, Feleke Z, Bikila D, Yaregal A, Demisie A, Ali S, et al. Drug and Therapeutics Committee (DTC) evolvement and expanded scope in Ethiopia. Gates Open Res. 2023; 5:70.

[9] Vogenberg FR, Gomes J. The Changing Roles of P & T Committees A Look Back at the Last Decade and a Look Forward to 2020. 2020;39(11).

[10] Mashaba TP, Matlala M, Godman B, Meyer JC, Mashaba TP, Matlala M, et al. Expert Review of Clinical Pharmacology Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals Implementation and monitoring of decisions by pharmacy and therapeutics. Expert Rev Clin Pharmacol [Internet]. 2018;00(00):1–10. Available from: https://doi.org/10.1080/17512433.2018.1545572.

[11] Yang J, Yu- LZMS. Evaluating the effectiveness of drug and therapeutics committees (DTCs) in controlling irrational drug use: A retrospective analysis. 2022;(December 2021):995–1001.

[12] Perrone J, Nelson LS. Pharmacy and Therapeutics Committees: Leadership Opportunities in Medication Safety for Medical Toxicologists. 2011;99–102.

[13] Matlala M, Gous AGS, Godman B, Meyer JC, Matlala M, Gous AGS, et al. Expert Review of Clinical Pharmacology Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert Rev Clin Pharmacol [Internet]. 2017;00(00):1–8. Available from: https://doi.org/10.1080/17512433.2017.1364625.

[14] Marcos-rodríguez JA, Cordero-ramos J, Alvarado-fernández MD. Policy Multi-criteria Decision Analysis as a Decision-Support Tool for Drug Evaluation: A Pilot Study in Pharmacy. 2018.

[15] Santos-ramos B, Dura E. Literature review on the structure and operation of Pharmacy and Therapeutics Committees. 2011;475–83.

[16] Hoffmann M. The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees. 2013; 69:79–87.

[17] Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann C, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Systematic reviews and Meta-Analyses. 2021.

[18] Tricco AC, Lillie E, Zarin W, Brien KKO, Colquhoun H, Levac D, et al. R ESEARCH AND R EPORTING M ETHODS PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. 2018;(August 2016).

[19] Mak S, Thomas A. Steps for Conducting a Scoping Review. J Grad Med Educ. 2022;14(5):565–7.

[20] Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6.

[21] Maros H, Juniar S. Beginer’s guide for systematic reviews. 2016;1–23.

[22] Almeida CPB de, Goulart BNG de. How to avoid bias in systematic reviews of observational studies. Rev CEFAC. 2017;19(4):551–5.

[23] THe World Bank Group. Country classification by income [Internet]. [cited 2023 Aug 21]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/topics/19280-country-classification.

[24] Alefan Q, Alshareef S, Al-Shatnawi S. Drug, and therapeutics committees in jordanian hospitals: A nation-wide survey of organization, activities, and drug selection procedures. Pharm Pract (Granada). 2019;17(4):1–6.

[25] Plet HT, Hallas J, Nielsen GS, Kjeldsen LJ. Drug and Therapeutics Committees in Danish Hospitals: A Survey of Organization, Activities and Drug Selection Procedures. Basic Clin Pharmacol Toxicol. 2013;112(4):264–9.

[26] Puigventós F, Santos-Ramos B, Ortega A, Durán-García E. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals. Pharm World Sci. 2010;32(6):767–75.

[27] Kabba JA, Koroma MM, James PB, Kitchen C, Xu S, Chang J, et al. Pilot drug, and therapeutic committee programme in Sierra Leone: A descriptive mixed method study. Br J Clin Pharmacol. 2023;89(1):20–33.

[28] Ministry of Health. Medicine and Therapeutics Committees Manual. 2018;(December):173. Available from: https://health.go.ug/sites/default/files/MTC Manual FINAL_print copy_21st Jan_19 %281%29.pdf.

[29] Ministry of Health Kenya. Guidelines for the Establishment and Operationalization of Medicines and Therapeutics Committees. 2020;(October).

[30] Management Sciences for Health. Treatment Guidelines and Formulary Manuals. MDS-3Managing Access to Med Heal Technol. 2012;17.1-17.5.

[31] Ciccarello C, Leber MB, Leonard MC, Nesbit T, Petrovskis MG, Pherson E, et al. ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. Am J Heal Pharm. 2021;78(10):907–18.

[32] Mannebach MA, Ascione FJ, Gaither CA, Bagozzi RP, Cohen IA, Ryan ML. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Heal Pharm. 1999;56(7):622–8.

[33] Björkman IK, Bernsten CB, Schmidt IK, Holmström I. The role of drug and therapeutics committees: Perceptions of chairs and information officers. Int J Health Care Qual Assur. 2005;18(4):235–48.

[34] Ramli A, Aljunid SM, Sulong S, Yusof FA. Structures and activities of Drug and Therapeutic Committees in formulary management: findings from a national survey and key informant interviews. 2014;14(Suppl 1):2458.